| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2023-12-28 | Wool Kyle Michael | Dominari Holdings Inc. | 1,483,420 | 27.8% | EDGAR |
| SC 13D | 2023-12-28 | Hayes Anthony | Dominari Holdings Inc. | 317,310 | 5.3% | EDGAR |
| SC 13D/A | 2023-07-06 | Wool Kyle Michael | Dominari Holdings Inc. | 819,001 | 17.8% | EDGAR |
| SC 13D | 2022-12-28 | Wool Kyle Michael | Dominari Holdings Inc. | 279,304 | 5.1% | EDGAR |
| SC 13G | 2022-06-14 | INTRACOASTAL CAPITAL, LLC | AIkido Pharma Inc. | 159,805 | 3.0% | EDGAR |
| SC 13G/A | 2022-02-14 | CVI Investments, Inc. | AIkido Pharma Inc. | 0 | 0.0% | EDGAR |
| SC 13D | 2021-02-25 | FiveT Investment Management Ltd | AIkido Pharma Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2021-02-25 | CVI Investments, Inc. | AIkido Pharma Inc. | 5,000,000 | 6.1% | EDGAR |
| SC 13G | 2021-02-17 | AIkido Pharma Inc. | Hoth Therapeutics, Inc. | 1,130,674 | 9.7% | EDGAR |
| SC 13G/A | 2021-02-16 | CVI Investments, Inc. | AIkido Pharma Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-01-05 | SABBY MANAGEMENT, LLC | Aikido Pharma Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2020-04-24 | CVI Investments, Inc. | Aikido Pharma Inc. | 2,000,000 | 5.7% | EDGAR |
| SC 13G | 2020-04-24 | Altium Capital Management LP | Aikido Pharma Inc. | 2,000,000 | 5.7% | EDGAR |
| SC 13G | 2020-04-23 | INTRACOASTAL CAPITAL, LLC | Aikido Pharma Inc. | 549,708 | 1.6% | EDGAR |
| SC 13G | 2020-04-14 | SABBY MANAGEMENT, LLC | Aikido Pharma Inc. | 2,000,000 | 5.8% | EDGAR |
| SC 13G | 2020-03-13 | ARMISTICE CAPITAL, LLC | SPHERIX INC | 0 | 0.0% | EDGAR |
| SC 13G | 2020-03-12 | INTRACOASTAL CAPITAL, LLC | SPHERIX INC | 549,178 | 3.6% | EDGAR |
| SC 13G | 2020-02-28 | SPHERIX INC | Hoth Therapeutics, Inc. | 1,636,230 | 16.2% | EDGAR |
| SC 13D | 2020-01-14 | CBM BioPharma, Inc. | SPHERIX INC | 1,939,058 | 40.2% | EDGAR |
| SC 13G/A | 2017-02-14 | Anson Funds Management LP | SPHERIX INC | 0 | 0.0% | EDGAR |